Park Medi World Limited is a multi-speciality healthcare provider with a strong presence in North India. The company operates through the Park Group of Hospitals, managing 13 multi-specialty hospitals with a total bed capacity of 3,000 beds as of September 30, 2024.
The network spans Haryana, Delhi, Punjab, and Rajasthan, with facilities located in Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad, New Delhi, Patiala, Mohali, Jaipur, and Behror. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), while seven are also NABL-accredited for laboratory standards.
Park Medi World offers 30+ speciality and super-speciality services, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology. Its infrastructure includes:
- 805 ICU beds
- 63 operating theatres (OTs)
- 2 dedicated cancer units
- Oxygen generation plants across all hospitals
The company also invests in clinical research and healthcare innovation, supporting long-term growth and patient-centric care delivery.
Park Medi World has demonstrated consistent patient volumes:
- 40,368 in-patient admissions (six months ended Sept 30, 2024)
- 73,284 admissions in FY 2024
- 73,084 admissions in FY 2023
- 62,106 admissions in FY 2022
As of September 30, 2024, the company employed a workforce of over 5,200 professionals, comprising 891 doctors, 1,912 nurses, 671 medical professionals, and 1,761 support staff, ensuring comprehensive healthcare delivery across its hospital network.
Park Medi World IPO – Details
| IPO Opening Date | 10 December 2025 |
| IPO Closing Date | 12 December 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 5,67,90,123 Shares Worth ₹920.00 Crore Fresh Issue: 4,75,30,864 Shares Worth ₹770.00 Crore Offer For Sale: 92,59,259 Shares Worth ₹150.00 Crore |
| Face Value | ₹2 per equity share |
| IPO Price | ₹154 – ₹162 per share |
| Market Lot | 92 Shares |
| Min Order | 92 Shares [ 1 lot ] |
| Listing At | BSE, NSE |
| Register | Kfin Technologies Ltd. |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Park Medi World IPO – Date Schedule
| IPO Open Date | 10 December 2025 |
| IPO Close Date | 12 December 2025 |
| Basis of Allotment | 15 December 2025 |
| Initiation of Refund | 16 December 2025 |
| Credit of Shares to Demat Account | 16 December 2025 |
| IPO Listing Date | 17 December 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 12, 2025 |
Park Medi World IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 92 | ₹14,904 |
| Retail (Max) | 13 | 1,196 | ₹1,93,752 |
| S-HNI (Min) | 14 | 1,288 | ₹2,08,656 |
| S-HNI (Max) | 67 | 6,164 | ₹9,98,568 |
| B-HNI (Min) | 68 | 6,256 | ₹10,13,472 |
Competitive Strength
- Second largest chain of private hospitals in North India and largest private hospital chain in Haryana;
- Delivering high-quality and affordable healthcare with a diverse specialty mix;
- Track record of successfully acquiring and integrating hospitals;
- Strong operational and financial performance with diversified payor mix; and
- Doctor-led professional management team with industry experience.
Company Promoters
- Dr. Ajit Gupta
- Dr. Ankit Gupta
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2022 | ₹1,093.96 Cr | ₹815.59 Cr | ₹199.38 Cr | ₹517.42 Cr |
| 31 March 2023 | ₹1,272.18 Cr | ₹955.37 Cr | ₹228.19 Cr | ₹575.68 Cr |
| 31 March 2024 | ₹1,263.08 Cr | ₹1041.66 Cr | ₹152.01 Cr | ₹686.71 Cr |
| 31 March 2025 | ₹1,425.97 Cr | ₹1,139.30 Cr | ₹213.22 Cr | ₹682.07 Cr |
| 30 September 2025 | ₹823.39 Cr | ₹649.50 Cr | ₹139.14 Cr | ₹733.91 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 20.68% |
| ROCE | 17.47% |
| Debt/Equity | 0.61 |
| RoNW | 20.08% |
| PAT Margin | 15.30% |
| EBITDA Margin | 26.71% |
| Price to Book Value | 6.09 |
| Pre IPO | Post IPO | |
| EPS (₹) | 5.55 | 6.44 |
| P/E (x) | 29.21 | 25.14 |
Object Of The Issue
| Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|
| Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries. | ₹380.00 |
| Funding capital expenditure for the development of a new hospital and expansion of existing hospital by our certain Subsidiaries, Park Medicity (NCR) and Blue Heavens, respectively. | ₹60.50 |
| Funding capital expenditure for the purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri. | ₹27.46 |
| Unidentified inorganic acquisitions and general corporate purposes. |
Park Medi World IPO Peer Comparison
| S. No. | Face Value (₹) | Company Name | P/E Ratio |
|---|---|---|---|
| 1 | 5 | Apollo Hospitals Enterprise Limited | 73.43 |
| 2 | 10 | Fortis Healthcare Limited | 90.42 |
| 3 | 10 | Narayana Hrudalaya Limited | 50.10 |
| 4 | 10 | Max Healthcare Institute Limited | 101.54 |
| 5 | 2 | Krishna Institute of Medical Sciences Limited | 69.53 |
| 6 | 2 | Global Health Limited | 66.41 |
| 7 | 10 | Jupiter Lifeline Hospitals Ltd | 48.59 |
| 8 | 10 | Yatharth Hospital & Trauma Care Services Limited | 52.85 |
✅Strengths
- Strong presence in North India with 13 hospitals and ~3,000 beds.
- All NABH-accredited; 7 also NABL-accredited.
- 30+ specialities with advanced infra (805 ICU beds, 63 OTs, 2 cancer units).
- Steady in-patient growth across FY22–FY24.
- Large workforce of 5,200+ professionals.
⚠️Risks
- High debt and lease liabilities may impact cash flow.
- Heavy reliance on healthcare approvals and regulations.
- Regional concentration mainly in North India.
- Significant related party transactions.
- No dividend history; future payouts uncertain.
- Dependence on lease/management agreements for some hospitals.
Park Medi World IPO Promoter Holding
| Pre Issue Share Holding | 95.55% |
| Post Issue Share Holding | 82.89% |
Park Medi World IPO Prospectus
Company Contact Information
| Park Medi World Ltd. 12, Meera Enclave Near Keshopur, Bus Depot, Outer Ring Road, New Delhi 110018, Delhi New Delhi, New Delhi, 110018 Phone: + 91 124 696 000 Email: company.secretary@parkhospital.in Website: http://www.parkhospital.in/ |
Park Medi World IPO Registrar
| Kfin Technologies Ltd. Phone: 04067162222, 04079611000 Email: parkmedi.ipo@kfintech.com Website: https://ipostatus.kfintech.com/ |
Park Medi World IPO Lead Manager(s)
| 1. DAM Capital Advisors Limited 2. CLSA India Private Limited 3. Nuvama Wealth Management Limited 4. Intensive Fiscal Services Private Limited |
Park Medi World IPO FAQs
| What is Park Medi World IPO? Park Medi World IPO is a main-board IPO. The issue is priced at ₹154 to ₹162 per equity share. The IPO is to be listed on the BSE & NSE. |
| When will Park Medi World IPO open? The IPO is to open on 10 December 2025 for QIB, NII, and Retail Investors. |
| What is Park Medi World IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is Park Medi World’s IPO Size? Park Medi World IPO size is ₹920.00 Crore. |
| What is the Park Medi World IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 92 Shares with ₹14,904, while the maximum bid is 1196 Shares with ₹1,93,752. |
| What is the Park Medi World IPO Allotment Date? Park Medi World IPO allotment date is 15 December 2025. |
| What is the Park Medi World IPO Listing Date? Park Medi World IPO listing date is 17 December 2025. The IPO is to be listed on BSE and NSE. |
